The FDA has rejected vatiquinone, requesting that PTC run an additional study to prove the drug's efficacy prior to ...

RVPH READ THE FULL RVPH RESEARCH REPORT Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported 2Q:25 results, ...

The side effect is rare, according to a new study, but is also the subject of multiple lawsuits, including two filed by Long ...

The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...

MBX Biosciences Inc. (NASDAQ: MBX) is one of the best IPO stocks to buy according to Wall Street analysts. On June 16, MBX ...

Natco Pharma, with Lupen, launches Bosentan tablets in US after USFDA nod; bags 180-day exclusivity for treating pulmonary ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) saw its stock slide 5% after the U.S. Food and Drug Administration (FDA) declined to ...

The extension was needed to review newly submitted long-term clinical data for all patients in the pivotal study following an FDA information request.

MEXICO CITY (AP) — Boxer Julio César Chávez Jr. has been deported to Mexico, where he’s wanted for alleged cartel ties, ...

A research team used computer modeling to create a database of predicted chemical structures for improved detection of ...

Shattuck Labs, a biotechnology company with operations in Durham, stands to raise up to $103 million in a private placement ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has issued a ...